PTK2 and neoplasm: Together these data pinpoint FAK as a key regulator of the TIME and demonstrate the pleiotropic role of this adhesion-associated protein in different cellular contexts to generate potent anti-tumour immune responses, both from within cancer cells and other stromal cells in the TME, in addition to systemic immune populations (Figure 2).